Angiogenesis Inhibition

1. Introduction
Rüdiger Liersch, Wolfgang E. Berdel, Torsten Kessler

2. Angiopoietins
Yvonne Reiss

3. HIF-1α and Cancer Therapy
Mei Yee Koh, Taly R. Spivak-Kroizman, Garth Powis

4. Chemokines
Andreas Hippe, Bernhard Homey, Anja Mueller-Homey

5. Angiogenesis Inhibition in Cancer Therapy
Iris Appelmann, Rüediger Liersch, Torsten Kessler, Rolf M. Mesters, Wolfgang E. Berdel

6. Vascular Integrins: Therapeutic and Imaging Targets of Tumor Angiogenesis
Curzio Rüegg, Gian Carlo Alghisi

7. PDGF and Vessel Maturation
Carina Hellberg, Arne Östman, C.-H. Heldin

8. Lymphangiogenesis in Cancer: Current Perspectives
Rüediger Liersch, Christoph Biermann, Rolf M. Mesters, Wolfgang E. Berdel

9. Compounds in Clinical Phase III and Beyond
Torsten Kessler, Michael Bayer, Christian Schwöppe, Rüdiger Liersch, Rolf M. Mesters, Wolfgang E. Berdel

10. Metronomic Chemotherapy: Principles and Lessons Learned from Applications in the Treatment of Metastatic Prostate Cancer
Urban Emmenegger, Giulio Francia, Yuval Shaked, Robert S. Kerbel

11. Targeting Inflammatory Cells to Improve Anti-VEGF Therapies in Oncology
Hans-Peter Gerber, Ezogelin Olazoglu, Iqbal S. Grewal

12. Antibody-Based Vascular Tumor Targeting
Christoph Schliemann, Dario Neri

13. Caveolae and Cancer
Kerri A. Massey, Jan E. Schnitzer

Nyckelord: Medicine & Public Health, Oncology, Hematology, Cancer Research